Physician profile
William Fleischmann
NPI 1659349686
$1,175.99
in general payments reported to CMS, 2019-2025
10 companies · $492 in 2025
The $492 reported for 2025 was more than what 77% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $156 · 2021: $50.83 · 2022: $131 · 2023: $34.80 · 2024: $310 · 2025: $492.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $695 · Entertainment: $142.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $695.26 |
| Entertainment | $142.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $286.48 | 2023-2025 | Hydrus Microstent, Total30, Precision 1 |
| Coopervision INC. | $215.67 | 2024-2025 | Misight Contact Lens, Myday Contact Lens |
| Glaukos Corporation | $201.79 | 2022-2025 | Idosetr |
| Optos, INC. | $142.23 | 2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $102.08 | 2019 | |
| Rxsight INC | $86.74 | 2024 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Genentech USA, INC. | $54.11 | 2019 | |
| Allergan, INC. | $50.83 | 2021 | |
| Biotissue Holdings INC. | $21.94 | 2024 | |
| Bausch & Lomb Americas INC. | $14.12 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Fleischmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.